By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences has received a $100,000 loan from its CEO, the company disclosed in a document filed with the US Securities and Exchange Commission today.

The loan from Richard Schumacher has a maturity date of Nov. 5 and can be extended by mutual agreement of both parties. It carries an annual interest rate of 20 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.